Jean is a Manager in Putnam’s Value, Pricing and Access (VPA) practice, advising biopharmaceutical and biotechnology clients on global pricing, access, and commercial strategy. He has experience across multiple therapeutic areas, including oncology, cardiometabolic disorders (e.g., MASH, chronic weight management, stroke), rare diseases, and autoimmune conditions.
Jean has led global projects across the EU4, the UK, Japan, China, and the US, supporting cross-functional teams in pricing and access strategy, launch sequencing, indication prioritization, and commercial opportunity assessment. His work spans early clinical development through post-launch lifecycle management, with particular focus on complex, multi-indication and multi-market engagements.
Before joining Putnam, Jean held roles in life sciences consulting and industry, where he supported commercial due diligence and pricing and access strategies for rare disease and oncology assets. He holds a Master’s in Engineering from Ecole Centrale de Lyon and a Master’s in Occupational and Organizational Psychology from Université Lyon 2.